Jerry Kanellos
Follow
Get notifications in MyBN when activity occurs.
Jerry Kanellos
Chief Operating Officer / Immuron
Dr Jerry Kanellos has over 20 years of experience in the pharmaceutical and biotechnology industry and has held leadership roles in business development, project management, intellectual property portfolio management, research and development.
Dr Kanellos has worked as a consultant to the biotechnology industry and has provided development & commercialisation strategies for various bodies including academic institutes, private and public-listed companies, and government departments. He has also been involved in the establishment and management of several startup biotechnology companies.
During his 10-year tenure in research and development at CSL, Dr Kanellos gained considerable experience in the drug development process, formulation development through to pharmaceutical scale-up and cGMP manufacture, successfully leading the chemistry manufacturing and controls (CMC) programs for the approval, manufacture and product launches.
He holds a PhD in Medicine from the University of Melbourne.
Dr Kanellos has worked as a consultant to the biotechnology industry and has provided development & commercialisation strategies for various bodies including academic institutes, private and public-listed companies, and government departments. He has also been involved in the establishment and management of several startup biotechnology companies.
During his 10-year tenure in research and development at CSL, Dr Kanellos gained considerable experience in the drug development process, formulation development through to pharmaceutical scale-up and cGMP manufacture, successfully leading the chemistry manufacturing and controls (CMC) programs for the approval, manufacture and product launches.
He holds a PhD in Medicine from the University of Melbourne.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 766th | Immuron | 6% | -10% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Immuron | $8.3m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Chief Operating Officer, Immuron | 03 Nov 2020 |
